Look at a company’s domain name, and you can often guess how far it has gone. Early-stage startups stretch for what’s available, while later-stage companies tend to own exactly what they say they are.
Grails’ Funding Stage Benchmark makes that shift visible. Drawing on data from 20,330 funded startups, the tool shows how domain choices evolve as companies raise capital, with a clear pattern: the higher the funding stage, the more likely a company operates on an exact brand match .com.
Reading the Data on Funding Stages
Grails’ Funding Stage Benchmark turns domain naming into something you can evaluate with context. It groups companies by stage and classifies their domain name as Exact Brand Match (EBM), modified .com, or non .com.
In practice, you select your current or target stage, whether that is pre-seed, seed, or later rounds, and the tool shows how your cohort is distributed across those domain name types.
What stands out is how consistent the progression is. At the pre-seed level, only around 42–43% of companies operate on an EBM domain name, while close to 40% rely on non .com domains. By the time companies reach Series A, the share of EBM domains begins to climb and non .com usage starts to decline. By Series C, nearly 60% of companies have secured their exact .com, and at growth stage that number rises above 62%, while non .com usage drops to roughly 17%.
By making the shift visible, the benchmark helps you see how domain name expectations change as companies grow, so you can judge whether your current domain still fits where you are heading or if it is starting to fall behind.
If you’re raising a Series A and operating on a quirky extension, you can estimate whether the cost of upgrading now might be smaller than a rebrand later. If you’re already at a growth stage and discover that 60% of your peers secured their exact .com, you have a clearer sense of what’s expected at your level.
How Domain Expectations Shift as Companies Scale
Grails’ Funding Stage Benchmark becomes more useful when read alongside the patterns described in When Domain Name Shortcuts Meet Series A Scale, The Domain Name That Survived Series A Meets Series B, and Series C: The Last Practical Window to Secure a Strategic-Grade Domain. Together, they explain why the data moves the way it does.
At Series A, naming decisions that felt settled early begin to resurface as exposure widens and the domain appears without context across investor materials and acquisition channels, where small inefficiencies start to matter; by Series B, the domain name becomes part of the company’s operating system, repeating across tools, workflows, and external touchpoints, so what once felt manageable begins to compound and affect trust and efficiency; by Series C, the domain takes on institutional weight, showing up in contexts where clarity is expected rather than negotiated, and the tolerance for workarounds drops as most companies converge on exact brand match .com domains.
Taken together, these pieces explain the progression visible in the benchmark. Early decisions are shaped by availability, but as companies grow those decisions are tested under broader exposure, stricter expectations, and more complex systems. The movement toward EBM domain names is not a matter of preference or convention; it reflects how naming holds up under pressure as a company scales.
Where to Go from Here
The Funding Stage Benchmark is a tool for making those hidden pressures explicit. It lets you compare your domain to thousands of peers at the same stage and see how naming strategies correlate with funding success. If you’re operating on a workaround, the data and the patterns above provide a clearer sense of when that choice will start costing you.
If you’re already considering a move, Grails’ data suggests you’re in good company, as the further along you are, the more your peers have upgraded. Founders evaluating stronger naming options can also post a request and review domain names aligned with the next stage of their company’s growth.